2026-10-11T02:54:12Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34040684 2026-10-01T07:20:05Z category_37339 category_37351 category_37360 category_37366 category_37375 portal_1012 item_type_6 month_year_10_2026

Supplementary Data 1 from Molecular Profiling of Tisotumab Vedotin–Treated Patients Identifies Immune Pathways Associated with Clinical Activity Sriram Sridhar (25153829) M. Guy Roukens (25153832) Christina Y. Yu (25153835) Tim Dielen (25153838) Berris van Kessel-Welmers (25153841) Han Si (15035273) Steven Xu (25153844) Lauren K. Brady (22687869) Merzu Belete (25153847) Mark Bieda (25153850) Khyati N. Shah (25153853) Regina Aquino (25153856) Denise Gallagher (25153859) Craig J. Thalhauser (25153862) Brandon W. Higgs (15035279) Mark Fereshteh (25153865) Maria Jure-Kunkel (15117740) Jeffrey R. Harris (17886109) Cancer Tumor Biology Therapeutic Research and Development Clinical Research and Trials Methods and Technology Biological Agents & Therapies Antibody-drug conjugates Clinical-stage Research Computational Methods Gene expression profiling Gynecological Cancers Cervical cancer Preclinical Models In vitro models of cancer Tumor Microenvironment Immune cells and the microenvironment <p>Supplemental Figures</p> 2026-10-01T00:00:00Z Text Journal contribution 10.1158/1078-0432.34040684 https://figshare.com/articles/journal_contribution/Supplementary_Data_1_from_Molecular_Profiling_of_Tisotumab_Vedotin_Treated_Patients_Identifies_Immune_Pathways_Associated_with_Clinical_Activity/34040684 CC BY